Urokinase-Type Plasminogen Activator Receptor (uPAR) PET/MRI of Prostate Cancer for Noninvasive Evaluation of Aggressiveness: Comparison with Gleason Score in a Prospective Phase 2 Clinical Trial

The aim of this study was to evaluate the correlation between uptake of the PET ligand (68)Ga-NOTA-AE105, targeting the urokinase-type plasminogen activator receptor (uPAR), and Gleason score in patients undergoing prostate biopsy. Methods: Patients with clinical suspicion of prostate cancer (PCa) o...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Nucl Med
Hlavní autoři: Fosbøl, Marie Øbro, Kurbegovic, Sorel, Johannesen, Helle Hjorth, Røder, Martin Andreas, Hansen, Adam Espe, Mortensen, Jann, Loft, Annika, Petersen, Peter Meidahl, Madsen, Jacob, Brasso, Klaus, Kjaer, Andreas
Médium: Artigo
Jazyk:Inglês
Vydáno: Society of Nuclear Medicine 2021
Témata:
Oncology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8049344/
https://ncbi.nlm.nih.gov/pubmed/32764119
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2967/jnumed.120.248120
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky